Company intelligence / Profile preview

Xsolis

Franklin, Tennessee, United States

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Xsolis has developed and deployed Dragonfly, an AI-driven platform for real-time predictive analytics in healthcare, primarily focused on optimizing medical necessity decision-making, utilization management, reduction of administrative waste, and payer-provider alignment. Their solutions are in commercial use across more than 500 hospitals and health plans, with billions of predictions made and over $1.5 billion in operational savings reported. Clinical results pertain primarily to operational, financial, and process efficiency endpoints rather than drug or direct clinical trial outcomes.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Beacon Health SystemHumana

Beyond the preview

Go deeper on Xsolis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xsolis.

Explore the full profile